Yeager, A M; Uhas, K A; Coles, C D et al. (2000) Bone marrow transplantation for infantile ceramidase deficiency (Farber disease). Bone Marrow Transplant 26:357-63
|
Archer, D R; Turner, C W; Yeager, A M et al. (1997) Sustained multilineage engraftment of allogeneic hematopoietic stem cells in NOD/SCID mice after in utero transplantation. Blood 90:3222-9
|
Mogul, M J; Forte, K J; Holland, H K et al. (1997) Steroid-refractory cutaneous graft-versus-host disease after transplantation of haploidentical parental CD34+ cells in children with Down's syndrome and recurrent acute leukemia. J Pediatr Hematol Oncol 19:142-4
|
Turner, C W; Yeager, A M; Waller, E K et al. (1996) Engraftment potential of different sources of human hematopoietic progenitor cells in BNX Mice. Blood 87:3237-44
|
Yeager, A M (1993) Recent developments in experimental bone marrow transplantation. Curr Opin Oncol 5:282-9
|
Yeager, A M; Shinn, C; Shinohara, M et al. (1993) Hematopoietic cell transplantation in the twitcher mouse. The effects of pretransplant conditioning with graded doses of busulfan. Transplantation 56:185-90
|
Yeager, A M; Shinn, C; Farmer, E R et al. (1992) Growth retardation and depigmentation of hair after high-dose busulfan and congenic hematopoietic cell transplantation in mice. Bone Marrow Transplant 9:199-204
|
Yeager, A M; Shinohara, M; Shinn, C (1991) Hematopoietic cell transplantation after administration of high-dose busulfan in murine globoid cell leukodystrophy (the twitcher mouse). Pediatr Res 29:302-5
|
Yeager, A M (1991) Pediatric bone marrow transplantation. Pediatr Rev 12:364-71
|
Yeager, A M; Shinn, C; Pardoll, D M (1991) Lymphoid reconstitution after transplantation of congenic hematopoietic cells in busulfan-treated mice. Blood 78:3312-6
|
Showing the most recent 10 out of 11 publications